Epitopea is a biotechnology company developing cancer treatments that harness the body’s immune system to fight cancer.
By using its sophisticated, proprietary platform, Epitopea is capable of identifying markers (called antigens) that are physically presented on the surface of cancer cells and thus recognisable by the immune system. By selecting those markers that are specific to cancer and shared between different patients, Epitopea is seeking to create novel, safe, off-the-shelf cancer vaccines capable of training the immune system to recognise these markers and attack the cells that present them.
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. Without these cookies, some parts of our site or the service being requested will be impossible to provide.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.